Clinical Trial Update: TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1/2 trial of TLK286 in combination with carboplatin for recurrent ovarian cancer. The study has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• TLK286

Snippet

Sponsor: Telik | Conditions: Ovarian Neoplasms | Phase 1, Phase 2 | Status: COMPLETED